BE849811A - Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation. - Google Patents
Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation.Info
- Publication number
- BE849811A BE849811A BE173598A BE173598A BE849811A BE 849811 A BE849811 A BE 849811A BE 173598 A BE173598 A BE 173598A BE 173598 A BE173598 A BE 173598A BE 849811 A BE849811 A BE 849811A
- Authority
- BE
- Belgium
- Prior art keywords
- montmorillonite
- weight
- emi
- treatment
- papaya
- Prior art date
Links
- 208000007163 Dermatomycoses Diseases 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 5
- 239000000203 mixture Substances 0.000 claims description 24
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 claims description 22
- 229910052901 montmorillonite Inorganic materials 0.000 claims description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 241000219173 Carica Species 0.000 claims description 13
- 235000009467 Carica papaya Nutrition 0.000 claims description 13
- 210000002683 foot Anatomy 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 9
- 201000003929 dermatomycosis Diseases 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 2
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 19
- 201000004647 tinea pedis Diseases 0.000 description 19
- 230000000694 effects Effects 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000000126 substance Substances 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000011276 wood tar Substances 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/22—Cysteine endopeptidases (3.4.22)
- C12Y304/22002—Papain (3.4.22.2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15176A JPS5283903A (en) | 1976-01-02 | 1976-01-02 | Medicine for remedy of dermatophytosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE849811A true BE849811A (fr) | 1977-04-15 |
Family
ID=11466028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE173598A BE849811A (fr) | 1976-01-02 | 1976-12-23 | Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation. |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5283903A (enrdf_load_stackoverflow) |
| BE (1) | BE849811A (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61225126A (ja) * | 1985-02-19 | 1986-10-06 | チャールズ アレン ジャンセン | 無機鉱物化合物からなる医薬組成物 |
-
1976
- 1976-01-02 JP JP15176A patent/JPS5283903A/ja active Granted
- 1976-12-23 BE BE173598A patent/BE849811A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS613768B2 (enrdf_load_stackoverflow) | 1986-02-04 |
| JPS5283903A (en) | 1977-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1125172A (fr) | Composition medicamenteuse et procede de preparation | |
| El-Bahr | Curcumin regulates gene expression of insulin like growth factor, B-cell CLL/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats | |
| CA2513616A1 (fr) | Composition pour une administration par voie orale contenant des capsaicinoides | |
| BE849811A (fr) | Compositions pharmaceutiques pulverulentes pour le traitement de dermatomycoses pedis et leur procede de preparation. | |
| CH699182B1 (fr) | Mélanges de miel d'abeilles pour le traitement dermatologique des plaies chroniques. | |
| EP4153305B1 (fr) | Hydrolysat de protéines du tourteau des graines de moringa peregrina pour son application en tant que médicament, son procédé d'obtention et compositions pharmaceutiques et dermatologiques | |
| EP1902631A2 (fr) | Additif antioxydant naturel d'origine végétale destiné à la nutrition animale | |
| US4108984A (en) | Compositions and methods for the treatment of athlete's foot | |
| El-Bahr et al. | Hepatic gene expression of insulin like growth factor and selected antioxidants in diabetic rats treated with turmeric or black cumin seed | |
| KR101478196B1 (ko) | 꾸지뽕을 주성분으로 하는 항산화 및 당뇨병 예방용 조성물 | |
| EP3242674B1 (fr) | Compositions contenant de la curcumine à biodisponibilité améliorée | |
| BE1021928B1 (fr) | Composition a base d'huile de krill et d'extrait de curcuma | |
| WO2022090561A1 (fr) | Composition naturelle pour traitement gastrique, notamment pour le traitement d'ulcères gastriques, procédé de fabrication associé et application aux équidés | |
| EP2646501B1 (fr) | Films naturels biodegradables a base de co-produits issus de processus industriels de traitement de graines | |
| EP3600370B1 (fr) | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate | |
| Nwoye et al. | In vivo acute effects of orally administered hydro-ethanol extract of Catha edulis on blood glucose levels in normal, glucose-fed hyperglycemic, and alloxan-induced diabetic rats | |
| Ibrahem et al. | Effect of modified ketogenic diets on rats with induced obesity | |
| Mamadou et al. | Hepatoprotective Activity of Aqueous Extract of Cashew Apple Cake (Anacardium occidentale L.) in Rats and Mice | |
| WO2019080983A1 (fr) | Nouvelle formulation a base de chitosane et son procede de preparation. | |
| FR3141617A1 (fr) | Composition pour son utilisation dans le traitement d’un syndrome de l'intestin irritable et/ou dans le traitement d’une hyperperméabilité intestinale. | |
| EP0005404B1 (fr) | Produit cicatrisant extrait de la moelle osseuse d'animaux | |
| FR3064480A1 (fr) | Composition solide a base d'extraits vegetaux liquides et son procede de preparation. | |
| CA2792993A1 (fr) | Composition particuliere pour son application comme medicament | |
| BE1026269B1 (fr) | Formulation à propriétés anti-inflammatoires | |
| FR3070866A1 (fr) | Procede de preparation d'un comprime pour administration perlinguale et/ou sublinguale comprenant une ou plusieurs huiles essentielles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: SATO MASATARO Effective date: 19921231 |